MATTHEW BIEVER: Open Payments
NPI 1023227741 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,206 in 102 payments from 14 companies in 2025. Trend: 2023 $27,281 · 2024 $15,878 · 2025 $12,206
Speaker / faculty: $8,800Food & beverage: $1,706Honoraria: $1,700
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $8,976 |
| Axsome Therapeutics, Inc. | 3 | $1,733 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $448 |
| Otsuka America Pharmaceutical, Inc. | 17 | $299 |
| Teva Pharmaceuticals USA, Inc. | 17 | $221 |
| Alkermes, Inc. | 7 | $146 |
| Janssen Pharmaceuticals, Inc | 4 | $106 |
| Neurocrine BioSciences, Inc. | 5 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
Products named: VRAYLAR, Auvelity, CAPLYTA, ABILIFY ASIMTUFII, UZEDY, LYBALVI, INGREZZA, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
